Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

Figure 4

YB-1 is a high risk factor in low-risk patients. YB-1 is expressed in 34% (437/1292) of low-risk patients who received no systemic therapy. 'N' represents the number of patients who died from breast cancer (number of events) in each category. Survival was stratified based on whether tumors expressed YB-1 (light grey line) or did not (black line). YB-1, Y-box binding protein-1.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us